M Hong Nguyen Selected Research

Candidemia

4/2022	Candidemia Among Coronavirus Disease 2019 Patients in Turkey Admitted to Intensive Care Units: A Retrospective Multicenter Study.
1/2019	Diagnosing candidemia with the T2Candida panel: an instructive case of septic shock in which blood cultures were negative.
2/2018	Non-Culture Diagnostics for Invasive Candidiasis: Promise and Unintended Consequences.
1/2018	Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial.
1/2018	Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel.
1/2018	Diagnosing Invasive Candidiasis.
2/2016	Invasive Candidiasis in Various Patient Populations: Incorporating Non-Culture Diagnostic Tests into Rational Management Strategies.
1/2016	Diagnostic Methods for Detection of Blood-Borne Candidiasis.
12/2015	Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream Infection.
5/2013	Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Hong Nguyen Research Topics

Disease

36	Infections 03/2024 - 11/2005
17	Candidiasis (Moniliasis) 04/2023 - 10/2003
14	Candidemia 04/2022 - 08/2005
10	Invasive Candidiasis 11/2021 - 05/2006
9	Mycoses (Diseases, Fungus) 09/2023 - 01/2010
8	Bacteremia 12/2022 - 03/2015
6	Aspergillosis 01/2024 - 12/2012
6	COVID-19 12/2021 - 09/2020
5	Invasive Fungal Infections 12/2021 - 01/2010
4	Invasive Pulmonary Aspergillosis 01/2015 - 06/2007
3	Sepsis (Septicemia) 09/2023 - 01/2018
3	Pneumonia (Pneumonitis) 11/2021 - 01/2018
3	Neutropenia 01/2020 - 09/2010
3	Neoplasms (Cancer) 01/2017 - 06/2010
3	Hematologic Neoplasms (Hematological Malignancy) 01/2015 - 07/2011
2	Septic Shock (Toxic Shock Syndrome) 11/2023 - 12/2012
2	Mucormycosis 02/2022 - 01/2022
2	Cystic Fibrosis (Mucoviscidosis) 02/2018 - 01/2016
2	Breakthrough Infections 12/2014 - 01/2014
2	Skin Neoplasms (Skin Cancer) 12/2011 - 11/2010
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2011 - 11/2010
1	Liver Diseases (Liver Disease) 12/2021
1	Empyema 04/2021
1	Rupture 04/2021
1	Clostridium Infections 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Coinfection 09/2020
1	Reinfection 01/2020
1	Intraabdominal Infections 08/2019
1	Urinary Tract Infections (Urinary Tract Infection) 08/2019
1	Exanthema (Rash) 01/2017
1	Pseudomonas Infections 01/2017
1	Drug-Related Side Effects and Adverse Reactions 12/2016
1	Surgical Wound Infection 10/2016
1	Cholangitis 09/2016

Drug/Important Bio-Agent (IBA)

11	Carbapenems (Carbapenem Antibiotics)IBA 01/2023 - 08/2014
9	EchinocandinsIBA 11/2021 - 09/2012
8	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2017
8	Proteins (Proteins, Gene)FDA Link 01/2015 - 11/2005
7	Fluconazole (Zonal)FDA LinkGeneric 04/2023 - 08/2005
7	Voriconazole (Vfend)FDA LinkGeneric 02/2022 - 01/2010
7	ceftazidime drug combination avibactamIBA 08/2019 - 12/2016
6	polyglucosanIBA 01/2018 - 05/2012
6	galactomannanIBA 01/2015 - 06/2007
5	TriazolesIBA 09/2023 - 06/2010
5	Immunoglobulin G (IgG)IBA 05/2013 - 05/2006
4	AzolesIBA 09/2023 - 06/2010
4	Biomarkers (Surrogate Marker)IBA 06/2022 - 05/2013
4	Caspofungin (Cancidas)FDA Link 12/2013 - 09/2012
3	Amphotericin B (Amphotericin)FDA LinkGeneric 09/2023 - 01/2017
3	Antifungal AgentsIBA 06/2022 - 09/2015
3	isavuconazoleIBA 02/2022 - 12/2018
3	meropenem and vaborbactamIBA 01/2020 - 01/2019
3	posaconazole FDA Link 12/2019 - 06/2010
3	Colistin (Coly-Mycin)FDA Link 08/2019 - 06/2012
3	MannansIBA 02/2018 - 05/2013
3	Valganciclovir FDA Link 01/2014 - 09/2010
2	PorinsIBA 01/2020 - 03/2015
2	tazobactam drug combination ceftolozaneIBA 01/2018 - 01/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017 - 11/2005
2	Doripenem FDA Link 03/2015 - 06/2012
2	Antiviral Agents (Antivirals)IBA 08/2014 - 01/2014
2	Anidulafungin FDA Link 12/2013 - 08/2009
2	EnzymesIBA 08/2013 - 05/2008
2	AntibodiesIBA 04/2009 - 11/2008
2	Immunoglobulin M (IgM)IBA 05/2008 - 05/2006
2	AntigensIBA 05/2008 - 06/2003
2	Virulence Factors (Pathogenicity Factors)IBA 08/2006 - 09/2005
1	Dihydrotachysterol (AT 10)IBA 04/2022
1	Prednisone (Sone)FDA LinkGeneric 11/2021
1	FidaxomicinIBA 01/2021
1	Metronidazole (Metric)FDA LinkGeneric 01/2021
1	Vancomycin FDA LinkGeneric 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2020
1	SteroidsIBA 01/2020
1	Polymyxin B (Aerosporin)FDA LinkGeneric 08/2019
1	plazomicinIBA 08/2019
1	Polymyxins (Polymyxin)IBA 08/2019
1	Ceftazidime (Fortum)FDA LinkGeneric 01/2019
1	avibactamIBA 01/2019
1	Meropenem (Merrem)FDA LinkGeneric 01/2017
1	Itraconazole (Sporanox)FDA LinkGeneric 01/2017
1	Terbinafine (Lamisil)FDA LinkGeneric 01/2017
1	RNA (Ribonucleic Acid)IBA 09/2016
1	SuspensionsIBA 01/2016
1	AminoglycosidesIBA 01/2016

Therapy/Procedure

24	Therapeutics 03/2024 - 08/2005
5	Lung Transplantation 11/2021 - 01/2010
4	Drug Therapy (Chemotherapy) 01/2018 - 06/2010
2	Central Venous Catheters 04/2022 - 10/2020
2	Transplantation 12/2021 - 01/2012
2	Organ Transplantation 01/2017 - 11/2010
1	Intravenous Administration 09/2023
1	Bedding and Linens (Linens) 01/2022
1	Immunomodulation 12/2021
1	Home Nursing (Nursing, Home) 09/2020
1	Duration of Therapy 01/2018
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2018
1	Liver Transplantation 10/2016
1	Aftercare (After-Treatment) 09/2016